{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T06:57:20Z","timestamp":1777877840270,"version":"3.51.4"},"reference-count":36,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Vector-Borne and Zoonotic Diseases"],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>Lyme borreliosis incidence is increasing in several areas; moreover, it has recently gained the public's attention. Apart from erythema migrans, Lyme disease diagnosis relies (among others) on serology test; however, the prevalence of positive enzyme-linked immunosorbent assay (ELISA) and western blot (WB) assay has been poorly studied in the general population. We aimed to approach the seroprevalence of infection by Borrelia species responsible for Lyme disease in the French Isere department using city laboratories data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Methods:<\/jats:title>\n                    <jats:p>We retrieved all serological tests for Borrelia species responsible for Lyme disease performed in the two main networks of city laboratories between 2015 and 2020. All patients with both ELISA and WB IgG were considered seropositive.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      We analyzed 27,360 tests (ELISA\/ELISA+WB). Mean age was 50.9\u2009\u00b1\u200920.3 years (ranges: 0\u2013101), with 57.1% females. Overall, 11.7% had IgG detected by ELISA, and 4.7% had IgG detected by both ELISA and WB assay. Seropositive status was more frequent in males (7.0% vs. 2.9%,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Seropositivity rate increased with age after a first peak in childhood; men aged 61\u201370 years had the highest seropositivity rate (10.3%). In addition, seropositivity rate was higher in persons from a rural area. In multivariate analysis, older age, male gender and living in a rural area were independently associated with seropositivity. Seropositivity rate was stable on the 2017\u20132020 period.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The seroprevalence of infection by Borrelia species responsible for Lyme disease is high in Isere; this probably reduces the predictive positive value for Lyme disease of ELISA and WB IgG, suggesting that this serological test should not be performed for nonspecific symptoms.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/vbz.2023.0098","type":"journal-article","created":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T10:55:57Z","timestamp":1709636157000},"page":"196-200","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Seroprevalence of Infection by\n                    <i>Borrelia<\/i>\n                    Species Responsible for Lyme Disease in the French Alps: Analysis of 27,360 Serology Tests, 2015\u20132020"],"prefix":"10.1177","volume":"24","author":[{"given":"Kevin","family":"Stadelmann","sequence":"first","affiliation":[{"name":"Groupe de Recherche en Infectiologie Clinique, CIC1406, Inserm-Universit\u00e9 Grenoble Alpes\u2014CHUGA, Grenoble, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Forestier","sequence":"additional","affiliation":[{"name":"Infectious Disease Unit, Centre Hospitalier M\u00e9tropole Savoie, Chamb\u00e9ry, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Richalet","sequence":"additional","affiliation":[{"name":"Oriade-Noviale Laboratory, Meylan, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virgile","family":"Monnet","sequence":"additional","affiliation":[{"name":"Eurofins-Biomnis Laboratory, Lyon, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8282-9522","authenticated-orcid":false,"given":"Olivier","family":"Epaulard","sequence":"additional","affiliation":[{"name":"Groupe de Recherche en Infectiologie Clinique, CIC1406, Inserm-Universit\u00e9 Grenoble Alpes\u2014CHUGA, Grenoble, France."},{"name":"Infectious Disease Unit, Centre Hospitalier Unversitaire Grenoble-Alpes, Grenoble, France."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2024,4,8]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18062933"},{"key":"e_1_3_4_3_1","first-page":"155","article-title":"Seroprevalence of Lyme disease in southwest Asturias","volume":"38","author":"Barreiro-Hurle L","year":"2020","unstructured":"Barreiro-Hurle L, , Melon-Garcia S, , Seco-Bernal C, et al. Seroprevalence of Lyme disease in southwest Asturias. Enferm Infecc Microbiol Clin (Engl Ed), 2020; 38:155\u2013158.","journal-title":"Enferm Infecc Microbiol Clin (Engl Ed)"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ttbdis.2020.101628"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1089\/vbz.2006.0533"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12875-018-0729-2"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0243950"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-014-2129-4"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1089\/vbz.2016.1954"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-33136-0"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1007404620701"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.279.3.206"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.revmed.2018.04.002"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0175574"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12875-017-0636-y"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.medmal.2020.09.026"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu397"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.86a.19029"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1590\/S1517-838246320140698"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-021-05099-1"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1177\/00333549211026777"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid2502.180771"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid1712.110371"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7017a2"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/tme.12197"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid2109.150417"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1086\/374376"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1370\/afm.117"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.ss6622a1"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.02110s4607"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ttbdis.2014.12.006"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064110"},{"key":"e_1_3_4_33_1","first-page":"74","article-title":"An estimate of Lyme borreliosis incidence in Western Europe","volume":"39","author":"Sykes RA","year":"2017","unstructured":"Sykes RA, , Makiello P. An estimate of Lyme borreliosis incidence in Western Europe. J Public Health (Oxf), 2017; 39:74\u201381.","journal-title":"J Public Health (Oxf)"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ttbdis.2017.10.018"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2018.23.9.17-00384"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1080\/13814788.2020.1732347"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1007465305193"}],"container-title":["Vector-Borne and Zoonotic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/vbz.2023.0098","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/vbz.2023.0098","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/vbz.2023.0098","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:03:24Z","timestamp":1777590204000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/vbz.2023.0098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["10.1089\/vbz.2023.0098"],"URL":"https:\/\/doi.org\/10.1089\/vbz.2023.0098","relation":{},"ISSN":["1530-3667","1557-7759"],"issn-type":[{"value":"1530-3667","type":"print"},{"value":"1557-7759","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4]]}}}